Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hepatitis C in Opiate Maintenance Therapy Patients
NCT01045278Phase 4Completed
- Sponsor
- Region Skåne
- Start
- Apr 2008
- Primary completion
- Sep 2013
- Modality
- Polymer-based Nanoparticles, Orthosteric Ligands, Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 4 trial of peginterferon alfa-2b, ribavirin in hepatitis C virus infection, sponsored by Region Skåne. Started Apr 2008; status: completed.
02
Drugs
peginterferon alfa-2bribavirin
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT01045278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01045278.